Welcome to our dedicated page for Unilever SEC filings (Ticker: UL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Unilever plc (UL) reports to the U.S. Securities and Exchange Commission as a foreign private issuer, primarily through Form 6-K current reports. The SEC filings page for UL on Stock Titan brings together these regulatory documents and pairs them with AI-generated summaries to help readers understand key points in each filing.
Recent Form 6-K filings illustrate several types of information Unilever discloses. Capital structure updates appear in voting rights and capital notices, which state the total number of ordinary shares in issue, the number of shares held in treasury and the number of shares with voting rights. Other filings describe the cancellation of treasury shares, including the dates of cancellation and the resulting share counts, giving investors visibility into changes in the company’s equity base.
Unilever’s filings also cover corporate transactions and restructuring. Exhibits to Form 6-Ks dated 5 December 2025 and 9 December 2025 refer to the demerger of Unilever’s Ice Cream Business, including an update and a completion notice. Another Form 6-K on 9 December 2025 references an exhibit on an update to the share consolidation ratio. These documents provide formal details on structural changes that may affect shareholders.
In addition, Unilever files extensive disclosures on transactions by persons discharging managerial responsibilities (PDMRs). These sections list purchases, dividend reinvestments and dividend equivalent accruals in Unilever PLC ordinary shares and American Depositary Receipts, including prices, volumes, transaction dates and trading venues such as the London Stock Exchange, Amsterdam Stock Exchange and New York Stock Exchange.
On Stock Titan, AI tools can highlight the main topics in each Unilever filing—such as share capital movements, insider transactions or demerger milestones—and explain technical terms in plain language. Users can quickly locate filings related to voting rights, treasury share cancellations, demerger documentation or PDMR transactions, and use the structured data to track how UL’s regulatory disclosures evolve over time.
McCormick & Company entered into definitive agreements to combine with Unilever Foods via a multi-step transaction. The transactions include a Distribution of SpinCo shares, two-step mergers, and related agreements (Merger Agreement, Separation and Distribution Agreement, Employee Matters Agreement) dated March 31, 2026. The deal contemplates McCormick issuing voting and non-voting common stock to SpinCo shareholders and a 364-day senior unsecured bridge facility of up to $15.7 billion. Completion is subject to McCormick shareholder approval of a Share Issuance and Charter Amendment, regulatory clearances, effectiveness of an S-4 registration statement, financing, and other customary conditions.
McCormick & Company presented a town hall describing the proposed combination with Unilever Foods, framing it as a strategic deal to create a larger global flavor company. The presentation cites a combined company FY25 net sales figure of $20B and highlights 1% to 3% organic sales guidance for 2026 alongside an Adjusted EPS target of $3.05 to $3.13. The slides disclose transaction-related risks, required regulatory and shareholder approvals, and near-term business continuity: "Business as Usual."
Unilever PLC reported an update on its voting rights and share capital. As at 31 March 2026, the company had 2,185,205,247 issued ordinary shares of 3 1/2p each, with no treasury shares. Of these, 256,282 shares were held within the Unilever group and their voting rights are not exercisable.
This leaves 2,184,948,965 shares with voting rights. Shareholders may use this figure as the denominator when calculating whether they must notify their interest, or any change in their interest, under the UK Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.
Unilever described a growth-led separation of its Foods business and a combination of Unilever Foods with McCormick, creating a global flavor company and leaving a EUR 39 billion Home & Personal Care (HPC) pure-play. The transaction terms cited an ~ $45 billion enterprise value for Unilever Foods, pro forma combined sales of $20 billion and 21% operating margin (2025 pro forma). Unilever will receive $15.7 billion in cash, 65% of equity in the combined company (Unilever shareholders to own 55% diluted), and retain a 9.9% stake subject to a one-year lock-up. Management expects ~$600 million annual run-rate synergies by year 3 and announced a EUR 500 million one-off restructuring to address stranded costs; closing is expected by mid-2027, subject to approvals.
McCormick and Unilever management presented a transaction to combine McCormick with Unilever Foods, targeting closing by mid 2027, subject to shareholder and regulatory approvals and other customary closing conditions. The combined company would keep McCormick's global headquarters in Hunt Valley, Maryland, maintain Unilever's R&D presence in the Netherlands, and pursue a secondary European listing. Management cited approximately $600 million of identified cost synergies, emphasized retention of talent, and described Unilever becoming a focused home and personal care pure play with EUR 39 billion of revenues.
McCormick & Company and Unilever Foods announced a proposed combination structured as a Reverse Morris Trust in which McCormick will issue a fixed number of shares and Unilever will receive $15.7 billion in cash. The transaction implies an enterprise value of $44.8 billion for Unilever Foods and $21 billion for McCormick, and uses a parity multiple of 13.8x calendar 2025 EBITDA.
The pro forma combined company is presented with $20 billion of 2025 net sales and a 21% operating margin on a pro forma basis, expected to expand to about 23%-25% by year 3. Management expects approximately $600 million of annual run-rate cost synergies (with ~2/3 realized by year 2) and plans to reinvest roughly $100 million into brands. Pro forma ownership at closing is expected to be 65% for Unilever/its shareholders and 35% for McCormick shareholders. Net leverage is expected at or below 4x at close, targeting about 3x within two years.
McCormick & Company and Unilever provide employee FAQs and extensive cautionary statements about forward-looking statements related to their pending transaction to combine Unilever Foods with McCormick. The document reiterates typical transaction risks, regulatory, financing and integration uncertainties and notes planned SEC filings, including a Form S-4 for McCormick and a Form 10 for Unilever Foods. It urges reading the registration and proxy materials carefully and points readers to SEC and company investor websites for the formal filings and additional disclosures.
McCormick & Company and Unilever describe a pending transaction to combine McCormick with Unilever Foods. The communication is largely a cautionary forward-looking statement section that lists risks, required regulatory and shareholder approvals, financing and integration uncertainties, and potential costs. The companies note that Unilever Foods historical figures are management estimates and that McCormick consolidated 100% of McCormick de Mexico after acquiring an additional 25% ownership interest in January 2026, raising its stake to 75%.
The parties state they will file SEC materials including a Form S-4 proxy/prospectus and a Form 10 for Unilever Foods, and that non-GAAP measures (EBITDA, Adjusted EBITDA, Net Leverage) are used for illustrative purposes without forward-looking GAAP reconciliations. The document emphasizes that timing, approvals and financing are conditions to closing and warns that combined-company estimates are illustrative and not pro forma under Regulation S-X.